APA (7th ed.) Citation

L, Z., V, G., M, T., G, A., ML, B., I, C., . . . V, D. (2026). Beta cell function and insulin sensitivity during elexacaftor/tezacaftor/ivacaftor therapy in people with cystic fibrosis. Frontiers in endocrinology, 17, 1774728. https://doi.org/10.3389/fendo.2026.1774728

Chicago Style (17th ed.) Citation

L, Zazzeron, et al. "Beta Cell Function and Insulin Sensitivity During Elexacaftor/tezacaftor/ivacaftor Therapy in People with Cystic Fibrosis." Frontiers in Endocrinology 17 (2026): 1774728. https://doi.org/10.3389/fendo.2026.1774728.

MLA (9th ed.) Citation

L, Zazzeron, et al. "Beta Cell Function and Insulin Sensitivity During Elexacaftor/tezacaftor/ivacaftor Therapy in People with Cystic Fibrosis." Frontiers in Endocrinology, vol. 17, 2026, p. 1774728, https://doi.org/10.3389/fendo.2026.1774728.